T.Kawabe Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

T.Kawabe heeft een totaal eigen vermogen van ¥6.6B en een totale schuld van ¥2.4B, wat de schuld-eigenvermogensverhouding op 35.7% brengt. De totale activa en totale passiva bedragen respectievelijk ¥12.4B en ¥5.7B. De EBIT T.Kawabe is ¥224.0M waardoor de rentedekking 24.9 is. Het heeft contanten en kortetermijnbeleggingen van ¥1.5B.

Belangrijke informatie

35.7%

Verhouding schuld/eigen vermogen

JP¥2.37b

Schuld

Rente dekkingsratio	24.9x
Contant	JP¥1.53b
Aandelen	JP¥6.63b
Totaal verplichtingen	JP¥5.73b
Totaal activa	JP¥12.36b

Recente financiële gezondheidsupdates

These 4 Measures Indicate That T.Kawabe (TSE:8123) Is Using Debt Reasonably Well

Aug 07

Is T.Kawabe (TYO:8123) Using Too Much Debt?

Apr 16

Health Check: How Prudently Does T.Kawabe (TYO:8123) Use Debt?

Dec 30

Recent updates

These 4 Measures Indicate That T.Kawabe (TSE:8123) Is Using Debt Reasonably Well

Aug 07

Investors Appear Satisfied With T.Kawabe & Co., Ltd.'s (TSE:8123) Prospects As Shares Rocket 41%

Mar 04

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥6.7B ) 8123 } overtreffen de korte termijn passiva ( ¥4.9B ).

Langlopende schulden: De kortetermijnactiva 8123 ( ¥6.7B ) overtreffen de langetermijnschulden ( ¥871.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 12.7% ) 8123 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 8123 is de afgelopen 5 jaar gestegen van 32.5% naar 35.7%.

Schuldendekking: De schuld van 8123 wordt niet goed gedekt door de operationele kasstroom ( 14.5% ).

Rentedekking: De rentebetalingen op de schuld van 8123 worden goed gedekt door EBIT ( 24.9 x dekking).

T.Kawabe Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

These 4 Measures Indicate That T.Kawabe (TSE:8123) Is Using Debt Reasonably Well

Is T.Kawabe (TYO:8123) Using Too Much Debt?

Health Check: How Prudently Does T.Kawabe (TYO:8123) Use Debt?

Recent updates

T.Kawabe & Co., Ltd. to Report Q2, 2025 Results on Nov 11, 2024

First quarter 2025 earnings released: JP¥101 loss per share (vs JP¥88.74 loss in 1Q 2024)

These 4 Measures Indicate That T.Kawabe (TSE:8123) Is Using Debt Reasonably Well

Investor sentiment deteriorates as stock falls 17%

T.Kawabe & Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024

Full year 2024 earnings released: EPS: JP¥146 (vs JP¥67.92 in FY 2023)

T.Kawabe & Co., Ltd., Annual General Meeting, Jun 26, 2024

Investor sentiment deteriorates as stock falls 16%

T.Kawabe & Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024

Upcoming dividend of JP¥80.00 per share

Investors Appear Satisfied With T.Kawabe & Co., Ltd.'s (TSE:8123) Prospects As Shares Rocket 41%

These Return Metrics Don't Make T.Kawabe (TSE:8123) Look Too Strong

Investor sentiment improves as stock rises 29%

Third quarter 2024 earnings released: EPS: JP¥52.04 (vs JP¥76.14 in 3Q 2023)

T.Kawabe & Co., Ltd. to Report Q3, 2024 Results on Feb 13, 2024

Second quarter 2024 earnings released: EPS: JP¥48.76 (vs JP¥30.67 loss in 2Q 2023)

T.Kawabe & Co., Ltd. to Report Q2, 2024 Results on Nov 13, 2023

First quarter 2024 earnings released: JP¥88.74 loss per share (vs JP¥78.33 loss in 1Q 2023)

T.Kawabe & Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings released: EPS: JP¥67.92 (vs JP¥200 loss in FY 2022)

T.Kawabe & Co., Ltd., Annual General Meeting, Jun 28, 2023

Third quarter 2023 earnings released: EPS: JP¥76.14 (vs JP¥45.46 in 3Q 2022)

T.Kawabe & Co., Ltd. to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: JP¥30.67 loss per share (vs JP¥69.56 loss in 2Q 2022)

No independent directors

Second quarter 2023 earnings released: JP¥30.67 loss per share (vs JP¥69.56 loss in 2Q 2022)

T.Kawabe & Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings released: JP¥78.33 loss per share (vs JP¥117 loss in 1Q 2022)

T.Kawabe & Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings released: JP¥200 loss per share (vs JP¥237 loss in FY 2021)

T.Kawabe & Co., Ltd., Annual General Meeting, Jun 28, 2022

Less than half of directors are independent

T.Kawabe & Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: JP¥69.56 loss per share (vs JP¥20.26 loss in 2Q 2021)

Full year 2021 earnings released: JP¥237 loss per share (vs JP¥7.12 loss in FY 2020)

Is T.Kawabe (TYO:8123) Using Too Much Debt?

Is T.Kawabe & Co., Ltd. (TYO:8123) At Risk Of Cutting Its Dividend?

Third quarter 2021 earnings released: JP¥43.82 loss per share (vs JP¥71.74 profit in 3Q 2020)

T.Kawabe & Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021

Health Check: How Prudently Does T.Kawabe (TYO:8123) Use Debt?

New 90-day high: JP¥1,080

New 90-day low: JP¥930

New 90-day low: JP¥954

T.Kawabe & Co., Ltd. to Report Q2, 2021 Results on Nov 13, 2020

New 90-day low: JP¥980

Earnings released

T.Kawabe & Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven